WallStreetZenWallStreetZen

NASDAQ: TXG
10x Genomics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
10x Genomics earnings were -$182.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TXG earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$49.0M, up 37.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TXG reported annual earnings of -$182.6M, with -28.4% growth.

TXG earnings history

Current Revenue
$610.8M
Current Earnings
-$182.6M
Current Profit Margin
-29.9%

TXG Return on Equity

Current Company
-25.4%
Current Industry
9.6%
Current Market
34.1%
TXG's Return on Equity (-25.4%)... subscribe to Premium to read more.
High Return on Equity Performance

TXG undefined

Current Company
-19.7%
Current Industry
4.5%
TXG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TXG announces earnings.

TXG undefined

Current Company
-22.18%
Current Industry
7.9%
TXG's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TXG vs Health Information Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TXG-$133.99M-$182.63MN/A-$1.52
HSTM$66.05M$20.01M+6.14%$0.66
EVH$80.06M-$93.45MN/A-$0.81
WEAV-$11.17M-$28.35MN/A-$0.40
TDOC-$587.01M-$1.00BN/A-$5.87
View Top Health Information Service Stocks

10x Genomics Earnings Reports & History FAQ

What were 10x Genomics's earnings last quarter?

On TXG's earnings call on Invalid Date, 10x Genomics (NASDAQ: TXG) reported Q4 2024 earnings per share (EPS) of -$0.41, up 0% year over year. Total TXG earnings for the quarter were -$49.03 million. In the same quarter last year, 10x Genomics's earnings per share (EPS) was -$0.41.

If you're new to stock investing, here's how to buy 10x Genomics stock.

Is 10x Genomics profitable or losing money?

As of the last 10x Genomics earnings report, 10x Genomics is currently losing money. 10x Genomics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$182.63 million, a 28.41% decrease year over year.

What was TXG's earnings growth in the past year?

As of 10x Genomics's earnings date in Invalid Date, 10x Genomics's earnings has grown year over year. TXG earnings in the past year totalled -$182.63 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.